This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04349/identifier/drugbank/
dctermshttp://purl.org/dc/terms/
n7http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB04349/identifier/chebi/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04349/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04349
rdf:type
n3:Drug
n3:description
A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations. [PubChem]
n3:group
experimental
owl:sameAs
n7:DB04349 n12:DB04349
dcterms:title
S-1,2-Propanediol
adms:identifier
n9:DB04349 n10:PGQ n11:29002
n3:IUPAC-Name
n4:271B521F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5225-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5224-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5221-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5222-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5223-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B521D-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B521E-363D-11E5-9242-09173F13E4C5 n4:271B521B-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B521C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B522B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B522C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5226-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5227-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5229-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5228-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B522A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5231-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5233-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5234-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5230-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B522F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5232-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5220-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B522D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B522E-363D-11E5-9242-09173F13E4C5